Screen every shift with CAM-ICU, prevent with the ABCDEF bundle, treat causes, and use antipsychotics only for distressing agitation.
At the bedside
- 1
Screen every shift
CAM-ICU (or ICDSC) when RASS ≥ -3; document result.
- 2
Look for causes (THINK)
Toxic (drugs: benzodiazepines, anticholinergics, steroids; withdrawal), Hypoxaemia, Infection/sepsis, Non-pharmacological factors (immobility, sleep deprivation, no glasses/hearing aids), K+/electrolytes/glucose/urea; also urinary retention, constipation, pain, alcohol withdrawal.
- 3
Prevent - ABCDEF bundle
Minimise benzodiazepines, light sedation, SAT/SBT, early and enhanced mobilisation, sleep hygiene (lights, noise, melatonin), reorientation, family involvement.
- 4
Hyperactive delirium endangering safety
Ensure analgesia; dexmedetomidine for agitation preventing extubation; short course of haloperidol 2.5-5 mg IV or quetiapine for distressing agitation; avoid physical restraints where possible.
- 5
Do not routinely use antipsychotics
Neither haloperidol nor ziprasidone shortened delirium (MIND-USA); PADIS 2025 makes no recommendation for routine antipsychotic treatment.
- 6
Follow-up
Delirium predicts long-term cognitive impairment: inform family, ICU follow-up clinic where available.
Distressing agitation in delirium
Haloperidol
- Dose
- 2.5-5 mg every 6-8 h as needed (max ~20 mg/day)
Check QTc; lower doses in elderly.
Persistent agitated delirium
Quetiapine
- Dose
- 25-50 mg every 12 h, titrate
Agitated delirium in ventilated patients
Dexmedetomidine
- Dose
- 0.2-1.4 mcg/kg/h
Sleep promotion
Melatonin
- Dose
- 3-10 mg at night
CAM-ICU
| Feature | Assessment |
|---|---|
| 1. Acute change or fluctuating course | Different from baseline, or fluctuating RASS/GCS in last 24 h |
| 2. Inattention | Squeeze hand on letter 'A' in SAVEAHAART: > 2 errors = positive |
| 3. Altered level of consciousness | Current RASS anything other than 0 |
| 4. Disorganised thinking | Yes/no questions (e.g. 'Will a stone float on water?') + command; > 1 error = positive |
Delirium = 1 + 2 + (3 or 4). Not assessable if RASS -4/-5.
References
- 1
- 2
- 3
- 4
- 5
- 6
Delirium management
Step 1 of ~3
Decision: CAM-ICU positive?
Based on Devlin JW, Skrobik Y, Gelinas C, et al; Ely EW, Inouye SK, Bernard GR, et al. Educational use; follow local protocol.
Pathophysiology
Delirium results from neuroinflammation, neurotransmitter imbalance (cholinergic deficiency, dopaminergic excess), impaired cerebral perfusion and oxygenation, sleep disruption and drug effects, superimposed on vulnerability (age, dementia, alcohol).
Evidence
- CAM-ICU validation [Ely 2001].
- MIND-USA: haloperidol/ziprasidone did not shorten delirium [Girard 2018]. AID-ICU: haloperidol did not significantly increase days alive and out of hospital [Andersen-Ranberg 2022].
- PADIS 2025: enhanced mobilisation and melatonin suggested; no recommendation on antipsychotics [Lewis 2025].
Controversies
- Antipsychotics for hyperactive delirium; prophylactic dexmedetomidine at night.
🇮🇳 India notes
- Validated Hindi and other Indian language versions of CAM-ICU are used in some centres; translate the inattention test letters appropriately.
- Families are often present for long hours in Indian ICUs - use them for reorientation and comfort.
References
- 1
- 2
- 3
- 4
- 5
- 6
Test yourself
Module quiz · score 70% to complete the module
Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.

